CND: Commission of Narcotic Drugs
The Commission of Narcotic Drugs was founded by the United Nations to oversee drug control and decisions at an international level.
Founded in 1946 The United Nations Commission of Narcotic Drugs was launched to implement and supervise international drug control and drug related treaties amongst countries in the United Nations. In 2020 the CND reclassified cannabis and cannabis resin to recognise its medicinal value, from its original spot alongside dangerously harmful drugs like heroin and fentanyl.
How much power does the CND hold?
The CND holds significant power in international drug control and policy. As the central policymaking body within the United Nations on drug-related issues, the CND plays a crucial role in shaping global drug policies and regulations.
Through its annual meetings, the CND reviews current drug trends and developments and determines strategies for tackling them. It also makes recommendations to member states on how to implement and enforce international drug control treaties.
Did the changes to the scheduling of cannabis and its derivatives have an impact?
Absolutely. The reclassification of cannabis and cannabis resin by the CND had far-reaching implications for drug policies around the world.
By recognising the medicinal value of cannabis, many countries have started to legalise its administration for medical purposes. This has led to a shift in public perception towards cannabis as more people see it as a legitimate medicine rather than a harmful illicit substance.
To find out more about the CND, click here
If you would like to learn more about medical cannabis in the UK, Releaf is here to help.